Corrigendum to “Severe fatigue in type 1 diabetes: Exploring its course, predictors and relationship with HbA1c in a prospective study” [Diabetes Res. Clin. Pract. 121 (2016) 127–134] (S0168822716306027) (10.1016/j.diabres.2016.09.011));Severe fatigue in type 1 diabetes: Exploring its course, predictors and relationship with HbA1c in a prospective study

Diabetes Research and Clinical Practice

Volumn 121, Issue , 2016, Pages 127-134

  Menting, Juliane ^a   Nikolaus, Stephanie ^a   van der Veld, William M ^b   Goedendorp, Martine M ^c   Tack, Cees J ^a   Knoop, Hans ^a,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

HbA1c; Persistent fatigue; Predictors of fatigue; Prospective design; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FATIGUE; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PAIN; PREDICTION; PREVALENCE; PROSPECTIVE STUDY; SELF CARE; SELF CONCEPT; SLEEP DISORDER; BLOOD; COMPLICATION; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; NETHERLANDS; QUESTIONNAIRE; SEVERITY OF ILLNESS INDEX;

BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FATIGUE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES;

EID: 84989360025     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2017.02.018     Document Type: Erratum

References (38)

1. [1] Goedendorp, M.M., Tack, C.J., Steggink, E., Bloot, L., Bazelmans, E., Knoop, H., Chronic fatigue in type 1 diabetes: highly prevalent but not explained by hyperglycemia or glucose variability. Diabetes Care 37 (2014), 73–80.
2. [2] Segerstedt, J.L.R., Eliasson, M., Patients with type 1 diabetes in Sweden experience more fatigue than the general population. J Clin Translational Endocrinol 2 (2015), 105–109.
3. [3] Fritschi, C., Quinn, L., Fatigue in patients with diabetes: a review. J Psychosom Res 69 (2010), 33–41.
4. [4] Van Hoogmoed, D., Fransen, J., Bleijenberg, G., van Riel, P., Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology 49 (2010), 1294–1302.
5. [5] Peters, J.B., Heijdra, Y.F., Daudey, L., Boer, L.M., Molema, J., Dekhuijzen, P.R., et al. Course of normal and abnormal fatigue in patients with chronic obstructive pulmonary disease, and its relationship with domains of health status. Patient Educ Couns 85 (2011), 281–285.
6. [6] Kalkman, J., Schillings, M., Van Der Werf, S., Padberg, G., Zwarts, M., van Engelen, B., et al. Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I. J Neurol Neurosur Ps 76 (2005), 1406–1409.
7. [7] Van Kessel, K., Moss-Morris, R., Willoughby, E., Chalder, T., Johnson, M.H., Robinson, E., A randomized controlled trial of cognitive behavior therapy for multiple sclerosis fatigue. Psychosom Med 70 (2008), 205–213.
8. [8] Voet, N., Bleijenberg, G., Hendriks, J., de Groot, I., Padberg, G., van Engelen, B., et al. Both aerobic exercise and cognitive-behavioral therapy reduce chronic fatigue in FSHD An RCT. Neurology 83 (2014), 1914–1922.
9. [9] Lasselin, J., Laye, S., Barreau, J.B., Rivet, A., Dulucq, M.J., Gin, H., et al. Fatigue and cognitive symptoms in patients with diabetes: relationship with disease phenotype and insulin treatment. Psychoneuroendocrino 37 (2012), 1468–1478.
10. [10] Fritschi, C., Quinn, L., Hacker, E.D., Penckofer, S.M., Wang, E., Foreman, M., et al. Fatigue in women with type 2 diabetes. Diabetes Educ 38 (2012), 662–672.
11. [11] Park, H., Park, C., Quinn, L., Fritschi, C., Glucose control and fatigue in type 2 diabetes: the mediating roles of diabetes symptoms and distress. J Adv Nurs 71 (2015), 1650–1660.
12. [12] Vercoulen, J.H., Swanink, C.M., Fennis, J.F., Galama, J.M., van der Meer, J.W., Bleijenberg, G., Dimensional assessment of chronic fatigue syndrome. J Psychosom Res 38 (1994), 383–392.
13. [13] Vercoulen JHMM, Bleijenberg G. Bleijenberg. De Checklist Individual Strength (CIS). In: Gedragstherapie, Houten: Bohn Stafleu Van Loghum; 1999.
14. [14] Bergner, M., Bobbitt, R.A., Carter, W.B., Gilson, B.S., The sickness impact profile: development and final revision of a health status measure. Med Care 19 (1981), 787–805.
15. [15] Craig, C.L., Marshall, A.L., Sjostrom, M., Bauman, A.E., Booth, M.L., Ainsworth, B.E., et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 35 (2003), 1381–1395.
16. [16] Prins, J.B., Bleijenberg, G., Bazelmans, E., Elving, L.D., de Boo, T.M., Severens, J.L., et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet 357 (2001), 841–847.
17. [17] Van Der Ven, N.C., Weinger, K., Yi, J., Pouwer, F., Ader, H., Van Der Ploeg, H.M., et al. The confidence in diabetes self-care scale: psychometric properties of a new measure of diabetes-specific self-efficacy in Dutch and US patients with type 1 diabetes. Diabetes Care 26 (2003), 713–718.
18. [18] Aaronson, N.K., Muller, M., Cohen, P.D., Essink-Bot, M.L., Fekkes, M., Sanderman, R., et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol 51 (1998), 1055–1068.
19. [19] Beck, A.T., Guth, D., Steer, R.A., Ball, R., Screening for major depression disorders in medical inpatients with the beck depression inventory for primary care. Behav Res Ther 35 (1997), 785–791.
20. [20] IBM Corp. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp. Released 2013.
21. [21] Jöreskog KG, Sörbom D. LISREL 8.80 for Windows [Computer software]. Lincolnwood, IL: Scientific Software International; 2006.
22. [22] Hosmer, D.W., Lemeshow, S., Introduction to the logistic regression model. Applied logistic regression, 2000, John Wiley & Sons, Hoboken, NJ, USA.
23. [23] Selig, J.P., Little, T.D., Autoregressive and cross-lagged panel analysis for longitudinal data. Laursen, B., Little, T.D., Card, N.E., (eds.) Handbook of developmental research methods, 2012, The Guilford Press, New York, 265–278.
24. [24] Daneman, D., Type 1 diabetes. The Lancet 367 (2006), 847–858.
25. [25] Saris, W.E., Satorra, A., Van der Veld, W.M., Testing structural equation models or detection of misspecifications?. Struct Equ Modeling 16 (2009), 561–582.
26. [26] Van Steenbergen, H.W., Tsonaka, R., Huizinga, T.W., Boonen, A., van der Helm-van, A.H., Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal study. RMD Open, 1, 2015, e000041.
27. [27] Alves, G., Wentzel-Larsen, T., Larsen, J., Is fatigue an independent and persistent symptom in patients with Parkinson disease?. Neurology 63 (2004), 1908–1911.
28. [28] Repping-Wuts, H., Fransen, J., van Achterberg, T., Bleijenberg, G., van Riel, P., Persistent severe fatigue in patients with rheumatoid arthritis. J Clin Nurs 16 (2007), 377–383.
29. [29] Anderson, R.J., Freedland, K.E., Clouse, R.E., Lustman, P.J., The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24 (2001), 1069–1078.
30. [30] Voermans, N.C., Knoop, H., van de Kamp, N., Hamel, B.C., Bleijenberg, G., van Engelen, B.G., Fatigue is a frequent and clinically relevant problem in Ehlers-Danlos syndrome. Semin Arthritis Rheu 40 (2010), 267–274.
31. [31] Van der Werf, S.P., Prins, J.B., Vercoulen, J.H., van der Meer, J.W., Bleijenberg, G., Identifying physical activity patterns in chronic fatigue syndrome using actigraphic assessment. J Psychosom Res 49 (2000), 373–379.
32. [32] Menting, J., Nikolaus, S., Wiborg, J.F., Bazelmans, E., Goedendorp, M.M., van Bon, A.C., et al. A web-based cognitive behaviour therapy for chronic fatigue in type 1 diabetes (Dia-Fit): study protocol for a randomised controlled trial. Trials, 16, 2015, 262.
33. [33] Singh, R., Kluding, P.M., Fatigue and related factors in people with type 2 diabetes. Diabetes Educ 39 (2013), 320–326.
34. [34] Lasselin, J., Layé, S., Dexpert, S., Aubert, A., Gonzalez, C., Gin, H., et al. Fatigue symptoms relate to systemic inflammation in patients with type 2 diabetes. Brain Behav Immun 26 (2012), 1211–1219.
35. [35] Flachenecker, P., Bihler, I., Weber, F., Gottschalk, M., Toyka, K.V., Rieckmann, P., Cytokine mRNA expression in patients with multiple sclerosis and fatigue. Mult Scler 10 (2004), 165–169.
36. [36] Pai, J.K., Pischon, T., Ma, J., Manson, J.E., Hankinson, S.E., Joshipura, K., et al. Inflammatory markers and the risk of coronary heart disease in men and women. New Engl J Med 351 (2004), 2599–2610.
37. [37] Stratton, I.M., Adler, A.I., Neil, H.A.W., Matthews, D.R., Manley, S.E., Cull, C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321 (2000), 405–412.
38. [38] Control D, Group CTR, The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 44 (1995), 968–983.